Assessments of antibody biodistribution

Continuous cultures of fused cells secreting antibody of predefined specificity

Köhler, G., & Milstein, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,200 · see citing works

Fcγ receptors as regulators of immune responses

Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947 · see citing works

Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment

Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438 · see citing works

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene

Cartron, G., Dacheux, L., Salles, G., Solal‐Céligny, P., BARDOS, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,902 · see citing works

IgG Fc Receptors

Ravetch, J. V., & Bolland, S. M. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.275 · Cited by 1,653 · see citing works

Fcγ Receptors: Old Friends and New Family Members

Nimmerjahn, F., & Ravetch, J. V. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.010 · Cited by 1,072 · see citing works

Antibody Pharmacokinetics and Pharmacodynamics

Lobo, E. D., Hansen, R. J., & Balthasar, J. P. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20178 · Cited by 909 · see citing works

An Fc receptor structurally related to MHC class I antigens

Simister, N. E., & Mostov, K. E. (1989) · Nature · doi:10.1038/337184a0 · Cited by 729 · see citing works

Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies

Keizer, R. J., Huitema, A. D. R., Schellens, J. H. M., & Beijnen, J. H. (2010) · Clinical Pharmacokinetics · doi:10.2165/11531280-000000000-00000 · Cited by 725 · see citing works

Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure.

Jain, R. K., & Baxter, L. T. (1988) · PubMed · Cited by 710 · see citing works

The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor.

Junghans, R. P., & Anderson, C. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5512 · Cited by 685 · see citing works

Studies on the distribution and fate of S35-labelled benzylpenicillin in the body.

Ullberg, S. (1954) · PubMed · Cited by 675 · see citing works

FcγRIV: A Novel FcR with Distinct IgG Subclass Specificity

Nimmerjahn, F., Bruhns, P., Horiuchi, K., & Ravetch, J. V. (2005) · Immunity · doi:10.1016/j.immuni.2005.05.010 · Cited by 656 · see citing works

High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.

Adams, G. P., Schier, R., McCall, A. M., Simmons, H. H., Horak, E. M., Alpaugh, R. K., Marks, J. D., & Weiner, L. M. (2001) · PubMed · Cited by 623 · see citing works

General Pharmacokinetic Model for Drugs Exhibiting Target-Mediated Drug Disposition

Mager, D. E., & Jusko, W. J. (2001) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/a:1014414520282 · Cited by 605 · see citing works

Elimination mechanisms of therapeutic monoclonal antibodies

Tabrizi, M. A., Tseng, C.-M. L., & Roskos, L. K. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03638-x · Cited by 479 · see citing works

Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human

Shah, D. K., & Betts, A. M. (2011) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-011-9232-2 · Cited by 424 · see citing works

Charge variants in IgG1

Khawli, L. A., Goswami, S., Hutchinson, R., Glover, Z. K., Yang, J., Wang, X., Yao, Z., Sreedhara, A., Cano, T., Tesar, D. B., et al. (2010) · mAbs · doi:10.4161/mabs.2.6.13333 · Cited by 420 · see citing works

Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier.

Juweid, M. E., Neumann, R. D., Paik, C. H., Pérez-Bacete, M., Sato, J., van Osdol, W. W., & Weinstein, J. N. (1992) · PubMed · Cited by 406 · see citing works

Effects of Charge on Antibody Tissue Distribution and Pharmacokinetics

Boswell, C. A., Tesar, D. B., Mukhyala, K., Theil, F.-P., Fielder, P. J., & Khawli, L. A. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100261d · Cited by 398 · see citing works

Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors

Rudnick, S. I., Lou, J., Shaller, C. C., Tang, Y., Klein-Szanto, A. J. P., Weiner, L. M., Marks, J. D., & Adams, G. P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2277 · Cited by 365 · see citing works

Comparisons of the Intraocular Tissue Distribution, Pharmacokinetics, and Safety of 125I-Labeled Full-Length and Fab Antibodies in Rhesus Monkeys Following Intravitreal Administration

Mordenti, J. J., Cuthbertson, R. A., Ferrara, N., Thomsen, K., Berleau, L. T., Ličko, V., Allen, P. C., Valverde, C. R., Meng, Y. G., Fei, D. T. W., et al. (1999) · Toxicologic Pathology · doi:10.1177/019262339902700507 · Cited by 350 · see citing works

Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport

Leach, J. L., Sedmak, D. D., Osborne, J. M., Rahill, B., Lairmore, M. D., & Anderson, C. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3317 · Cited by 348 · see citing works

Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice

Garg, A., & Balthasar, J. P. (2007) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-007-9065-1 · Cited by 329 · see citing works

In vivo Molecular Imaging of Cancer with a Quenching Near-Infrared Fluorescent Probe Using Conjugates of Monoclonal Antibodies and Indocyanine Green

Ogawa, M., Kosaka, N., Choyke, P. L., & Kobayashi, H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3116 · Cited by 327 · see citing works

Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice.

Covell, D. G., Barbet, J., Holton, O. D., BLACK, C. D. V., Parker, R. J., & Weinstein, J. N. (1986) · PubMed · Cited by 311 · see citing works

Biodistribution Mechanisms of Therapeutic Monoclonal Antibodies in Health and Disease

Tabrizi, M. A., Bornstein, G. G., & Suria, H. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9157-5 · Cited by 307 · see citing works

Trastuzumab

McKeage, K., & Perry, C. M. (2002) · Drugs · doi:10.2165/00003495-200262010-00008 · Cited by 292 · see citing works

Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice.

Baxter, L. T., Zhu, H. J., Mackensen, D. G., & Jain, R. K. (1994) · PubMed · Cited by 280 · see citing works

The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat

Jones, E. A., & Waldmann, T. A. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107116 · Cited by 279 · see citing works

Mediated efflux of IgG molecules from brain to blood across the blood–brain barrier

Zhang, Y., & Pardridge, W. M. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00242-9 · Cited by 272 · see citing works

In Vivo Deamidation Characterization of Monoclonal Antibody by LC/MS/MS

Huang, L., Lu, J., Wroblewski, V. J., Beals, J. M., & Riggin, R. M. (2005) · Analytical Chemistry · doi:10.1021/ac0494174 · Cited by 266 · see citing works

pH-dependent binding of immunoglobulins to intestinal cells of the neonatal rat.

Rodewald, R. (1976) · The Journal of Cell Biology · doi:10.1083/jcb.71.2.666 · Cited by 266 · see citing works

Reduced elimination of IgG antibodies by engineering the variable region

Igawa, T., Tsunoda, H., Tachibana, T., Maeda, A., Mimoto, F., Moriyama, C., Nanami, M., Sekimori, Y., Nabuchi, Y., Aso, Y., et al. (2010) · Protein Engineering Design and Selection · doi:10.1093/protein/gzq009 · Cited by 265 · see citing works

Antibody biodistribution coefficients: Inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human

Shah, D. K., & Betts, A. M. (2013) · mAbs · doi:10.4161/mabs.23684 · Cited by 262 · see citing works

Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice

Borvák, J. (1998) · International Immunology · doi:10.1093/intimm/10.9.1289 · Cited by 254 · see citing works

Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway

Bitonti, A. J., Dumont, J. A., Low, S. C., Peters, R., Kropp, K. E., Palombella, V. J., Stattel, J. M., Lu, Y., Tan, C. A., Song, J. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403235101 · Cited by 234 · see citing works

Fluorescence Imaging of Tumors In Vivo

Ballou, B. T., Ernst, L., & Waggoner, A. P. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053507324 · Cited by 233 · see citing works

Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies

Dostálek, M., Gardner, I. B., Gurbaxani, B. M., Rose, R. H., & Chetty, M. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-012-0027-4 · Cited by 231 · see citing works

Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies

Mould, D. R., & Green, B. (2010) · BioDrugs · doi:10.2165/11530560-000000000-00000 · Cited by 207 · see citing works

The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease

Akilesh, S., Petkova, S. B., Sproule, T. J., Shaffer, D. J., Christianson, G. J., & Roopenian, D. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18838 · Cited by 197 · see citing works

Physiological and pathological aspects of circulating immune complexes

Schifferli, J. A., & Taylor, R. P. (1989) · Kidney International · doi:10.1038/ki.1989.83 · Cited by 195 · see citing works

Antibodies and Antimatter: The Resurgence of Immuno-PET

Wu, A. M. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.056887 · Cited by 184 · see citing works

Monoclonal Antibody Clearance

Datta‐Mannan, A., Witcher, D. R., Tang, Y., Watkins, J. D., & Wroblewski, V. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607161200 · Cited by 171 · see citing works

Transcytosis and Catabolism of Antibody

Ghetie, V. F., & Ward, E. S. (2002) · Immunologic Research · doi:10.1385/ir:25:2:097 · Cited by 150 · see citing works

Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration

Zheng, Y., Tesar, D. B., Benincosa, L., Birnböck, H., Boswell, C. A., Bumbaca, D., Cowan, K. J., Danilenko, D. M., Daugherty, A. L., Fielder, P. J., et al. (2012) · mAbs · doi:10.4161/mabs.4.2.19387 · Cited by 149 · see citing works

A Predictive Model of Therapeutic Monoclonal Antibody Dynamics and Regulation by the Neonatal Fc Receptor (FcRn)

Ferl, G. Z., Wu, A. M., & DiStefano, J. J. (2005) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-7410-3 · Cited by 144 · see citing works

The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: a comparison of nine radiolabels.

Shih, L. B., Thorpe, S. R., Griffiths, G. L., Diril, H., Ong, G. L., Hansen, H. J., Goldenberg, D. M., & Mattes, M. J. (1994) · PubMed · Cited by 142 · see citing works

Humanized IgG1 Variants with Differential Binding Properties to the Neonatal Fc Receptor: Relationship to Pharmacokinetics in Mice and Primates

Datta‐Mannan, A., Witcher, D. R., Tang, Y., Watkins, J. D., Jiang, W., & Wroblewski, V. J. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.011734 · Cited by 135 · see citing works

Effect of Target Dynamics on Pharmacokinetics of a Novel Therapeutic Antibody against the Epidermal Growth Factor Receptor: Implications for the Mechanisms of Action

van Bueren, J. J. L., Bleeker, W. K., Bøgh, H. O., Houtkamp, M., Schuurman, J., van de Winkel, J. G. J., & Parren, P. W. H. I. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4010 · Cited by 127 · see citing works

Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia

Hansen, R. J., & Balthasar, J. P. (2002) · Blood · doi:10.1182/blood.v100.6.2087 · Cited by 125 · see citing works

Fc receptor signaling and trafficking: a connection for antigen processing

Amigorena, S., & Bonnerot, C. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01372.x · Cited by 123 · see citing works

Efflux of monoclonal antibodies from rat brain by neonatal Fc receptor, FcRn

Cooper, P. R., Ciambrone, G. J., Kliwinski, C. M., Maze, E., Johnson, L., Li, Q., Feng, Y., & Hornby, P. J. (2013) · Brain Research · doi:10.1016/j.brainres.2013.08.035 · Cited by 121 · see citing works

89Zr, a Radiometal Nuclide with High Potential for Molecular Imaging with PET: Chemistry, Applications and Remaining Challenges

Fischer, G., Seibold, U., Schirrmacher, R., et al. (2013) · Molecules · doi:10.3390/molecules18066469 · Cited by 120 · see citing works

Differential expression of Fcγ RIIA, Fcγ RIIB and Fcγ RIIC in hematopoietic cells: Analysis of transcripts

Cassel, D. L., Keller, M., Surrey, S., et al. (1993) · Molecular Immunology · doi:10.1016/0161-5890(93)90113-p · Cited by 117 · see citing works

Pharmacokinetics of Humanized Monoclonal Anti-Tumor Necrosis Factor-α Antibody and Its Neonatal Fc Receptor Variants in Mice and Cynomolgus Monkeys

Deng, R., Loyet, K. M., Lien, S., Iyer, S., DeForge, L. E., Theil, F., Lowman, H. B., Fielder, P. J., & Prabhu, S. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.031310 · Cited by 113 · see citing works

Effects of altered FcγR binding on antibody pharmacokinetics in cynomolgus monkeys

Leabman, M. K., Meng, Y. G., Kelley, R. F., DeForge, L. E., Cowan, K. J., & Iyer, S. (2013) · mAbs · doi:10.4161/mabs.26436 · Cited by 110 · see citing works

Interstitial transport of rabbit and sheep antibodies in normal and neoplastic tissues.

Clauss, M. A., & Jain, R. K. (1990) · PubMed · Cited by 109 · see citing works

Investigation of the Influence of FcRn on the Distribution of IgG to the Brain

Garg, A., & Balthasar, J. P. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9129-9 · Cited by 108 · see citing works

Evaluation of a Catenary PBPK Model for Predicting the In Vivo Disposition of mAbs Engineered for High-Affinity Binding to FcRn

Chen, Y., & Balthasar, J. P. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9395-9 · Cited by 105 · see citing works

Physiologically based pharmacokinetic model for T84.66: A monoclonal anti-CEA antibody

Urva, S., Yang, V. C.-M., & Balthasar, J. P. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21918 · Cited by 105 · see citing works

Pharmacokinetic Imaging

Fischman, A. J., Alpert, N. M., & Rubin, R. H. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241080-00003 · Cited by 102 · see citing works

Processing of antibody-radioisotope conjugates after binding to the surface of tumor cells

Mattes, M. J., Griffiths, G. L., Diril, H., Goldenberg, D. M., Ong, G. L., & Shih, L. B. (1994) · Cancer · doi:10.1002/1097-0142(19940201)73:3+ · Cited by 98 · see citing works

Engineered anti-CD70 antibody-drug conjugate with increased therapeutic index

McDonagh, C. F., Kim, K. M., Turcott, E., Brown, L. L., Westendorf, L., Feist, T., Sussman, D. R., Stone, I. J., Anderson, M. E., Miyamoto, J. B., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0295 · Cited by 95 · see citing works

FcγR: The key to optimize therapeutic antibodies?

Sibéril, S., Dutertre, C., Fridman, W. H., & Teillaud, J. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.12.003 · Cited by 92 · see citing works

Zirconium-labeled monoclonal antibodies and their distribution in tumor-bearing nude mice.

Meijs, W. E., Haisma, H. J., Klok, R. P., et al. (1997) · PubMed · Cited by 92 · see citing works

Fc receptors for IgG and antigen presentation on MHC class I and class II molecules

Amigorena, S., & Bonnerot, C. (1999) · Seminars in Immunology · doi:10.1006/smim.1999.0196 · Cited by 86 · see citing works

Evaluation of a peptide ELISA for the detection of rituximab in serum

Blasco, H., Lalmanach, G., Godat, E., et al. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.06.011 · Cited by 79 · see citing works

Measurement of macromolecular diffusion coefficients in human tumors

Brown, E. B., Boucher, Y., Nasser, S. M., et al. (2004) · Microvascular Research · doi:10.1016/j.mvr.2004.02.001 · Cited by 78 · see citing works

Investigation of the Role of FcγR and FcRn in mAb Distribution to the Brain

Abuqayyas, L., & Balthasar, J. P. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300214k · Cited by 77 · see citing works

Depression after successful treatment for nonsmall cell lung carcinoma

Uchitomi, Y., Mikami, I., Kugaya, A., Akizuki, N., Nagai, K., Nishiwaki, Y., Akechi, T., & Okamura, H. (2000) · Cancer · doi:10.1002/1097-0142(20000901)89:5 · Cited by 75 · see citing works

Simultaneous Analysis of Multiple Monoclonal Antibody Biotherapeutics by LC-MS/MS Method in Rat Plasma Following Cassette-Dosing

Li, H., Ortiz, R., Tran, L. T., et al. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9435-5 · Cited by 63 · see citing works

Compartmental Tissue Distribution of Antibody Therapeutics: Experimental Approaches and Interpretations

Boswell, C. A., Bumbaca, D., Fielder, P. J., & Khawli, L. A. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9374-1 · Cited by 62 · see citing works

Effect of FCGR2A and FCGR3A variants on CLL outcome

Dornan, D., Spleiss, O., Yeh, R.-F., Duchâteau-Nguyen, G., Dufour, A. M., Zhi, J., Robak, T., Si, M., Dmoszyńska, A., Solal‐Céligny, P., et al. (2010) · Blood · doi:10.1182/blood-2010-03-272765 · Cited by 61 · see citing works

The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: An autoradiographic study

Blumenthal, R. D., Fand, I., Sharkey, R. M., et al. (1991) · Cancer Immunology Immunotherapy · doi:10.1007/bf01741594 · Cited by 57 · see citing works

FcγRIIB as a modulator of autoimmune disease susceptibility

Tarasenko, T., Dean, J. A., & Bolland, S. M. (2007) · Autoimmunity · doi:10.1080/08916930701464665 · Cited by 57 · see citing works

Fc receptor-mediated binding and endocytosis by human mononuclear phagocytes: monomeric IgG is not endocytosed by U937 cells and monocytes.

Jones, D. H., Nusbacher, J., & Anderson, C. L. (1985) · The Journal of Cell Biology · doi:10.1083/jcb.100.2.558 · Cited by 52 · see citing works

Application of PBPK modeling to predict monoclonal antibody disposition in plasma and tissues in mouse models of human colorectal cancer

Abuqayyas, L., & Balthasar, J. P. (2012) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-012-9279-8 · Cited by 51 · see citing works

Nano-scale liquid chromatography/mass spectrometry and on-the-fly orthogonal array optimization for quantification of therapeutic monoclonal antibodies and the application in preclinical analysis

Duan, X., Dai, L.-P., Chen, S., Balthasar, J. P., & Qu, J. (2012) · Journal of Chromatography A · doi:10.1016/j.chroma.2012.06.007 · Cited by 48 · see citing works

Comparisons between two monoclonal antibodies that bind to the same antigen but have differing affinities: uptake kinetics and 125I-antibody therapy efficacy in multicell spheroids.

Langmuir, V. K., Mendonca, H. L., & Woo, D. V. (1992) · PubMed · Cited by 47 · see citing works

Application of knockout mouse models to investigate the influence of FcγR on the tissue distribution and elimination of 8C2, a murine IgG1 monoclonal antibody

Abuqayyas, L., & Balthasar, J. P. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.09.042 · Cited by 34 · see citing works

Pharmacokinetic mAb–mAb Interaction: Anti-VEGF mAb Decreases the Distribution of Anti-CEA mAb into Colorectal Tumor Xenografts

Abuqayyas, L., & Balthasar, J. P. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9357-2 · Cited by 29 · see citing works

Fluorescent labeling of proteins with Nile red and 2-methoxy-2,4-diphenyl-3(2H)-furanone: Physicochemical basis and application to the rapid staining of sodium dodecyl sulfate polyacrylamide gels and Western blots

Daban, J. (2001) · Electrophoresis · doi:10.1002/1522-2683()22:5 · Cited by 26 · see citing works

Pharmacokinetic study and Fcγ receptor gene analysis in two patients with rheumatoid arthritis controlled by low-dose infliximab

Nishio, S., Yamamoto, T., Kaneko, K., Tanaka-Matsumoto, N., Muraoka, S., Kaburaki, M., Kusunoki, Y., Takagi, K., & Kawai, S. (2009) · Modern Rheumatology · doi:10.1007/s10165-009-0158-0 · Cited by 21 · see citing works

Biodistributions of intact monoclonal antibodies and fragments of BLCA-38, a new prostate cancer directed antibody

Carter, T. E., Sterling-Levis, K., Ow, K. T., et al. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0460-1 · Cited by 19 · see citing works

Application of knockout mouse models to investigate the influence of FcγR on the pharmacokinetics and anti-platelet effects of MWReg30, a monoclonal anti-GPIIb antibody

Abuqayyas, L., Zhang, X., & Balthasar, J. P. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.01.001 · Cited by 17 · see citing works

In Vitro and In Vivo Methods for Assessing FcRn-Mediated Reverse Transcytosis Across the Blood–Brain Barrier

Caram‐Salas, N. L., Boileau, E., Farrington, G. K., Garber, E. A., Brunette, E., Abulrob, A., & Stanimirovic, D. B. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-191-8_26 · Cited by 17 · see citing works

Pharmacokinetic study and Fcγ receptor gene analysis in two patients with rheumatoid arthritis controlled by low-dose infliximab

Nishio, S., Yamamoto, T., Kaneko, K., et al. (2009) · Modern Rheumatology · doi:10.3109/s10165-009-0158-0 · Cited by 16 · see citing works

Limitations of Noncompartmental Pharmacokinetic Analysis of Biotech Drugs

Straughn, A. B. (2006) · doi:10.1002/9783527609628.ch7 · Cited by 14 · see citing works

Refinement of the Population Pharmacokinetic Model for the Monoclonal Antibody Matuzumab

Kuester, K., Kovar, A., Lüpfert, C., Brockhaus, B., & Kloft, C. (2009) · Clinical Pharmacokinetics · doi:10.2165/11313400-000000000-00000 · Cited by 12 · see citing works

Erratum to “Measurement of macromolecular diffusion coefficients in human tumors” [Microvasc.Res. 67 (2004) 231–236]

Brown, E. B., Boucher, Y., Nasser, S. M., et al. (2004) · Microvascular Research · doi:10.1016/j.mvr.2004.08.004 · Cited by 9 · see citing works

Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development

Ovacik, M., & Lin, K. (2018) · Clinical and Translational Science · doi:10.1111/cts.12567 · Cited by 299 · see citing works

Comparison of monoclonal antibody disposition predictions using different physiologically based pharmacokinetic modelling platforms

De Sutter, P.-J., Gasthuys, E., & Vermeulen, A. (2024) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-023-09894-4 · Cited by 8 · see citing works

Susquehanna Chorale Spring Concert "Roots and Wings"

Hawkins, D. (2017)

Genentech taps Affimed’s antibodies

Cross, R. (2018) · C&EN Global Enterprise · doi:10.1021/cen-09635-buscon15

KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK

Sari, D. (2023) · Jurnal Komplikasi Anestesi · doi:10.22146/jka.v5i1.7322

Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria

Dib, A., Puig, L. B., Salvadori, D., et al. (1988) · Arquivos Brasileiros de Cardiologia

Interleucinas na encefalopatia hipóxico-isquêmica

Ceccon, M. E. J. R. (2003) · Jornal de Pediatria · doi:10.1590/s0021-75572003000400002 · Cited by 14 · see citing works